logo
Plus   Neg
Share
Email

Intercontinental Hotels Q3 RevPAR Down; Says Confident In Financial Outcome

InterContinental Hotels Group plc (IHG.L,IHG) reported Friday that its third-quarter Group RevPAR was down 0.8 percent, impacted by tougher trading conditions in the US and China, and ongoing unrest in the Hong Kong SAR.

The company delivered a 4.7 percent increase in net system size to 865 thousand rooms, despite a strong comparable.

In the Americas, RevPAR was down 0.6 percent reflecting 0.6 percent drop in the US and 2 percent drop in Canada.

In Europe, Middle East, Asia & Africa, RevPAR was up 0.2 percent. Third-quarter RevPAR in Greater China was impacted by ongoing unrest in the Hong Kong SAR where RevPAR was down 36 percent.

The company said it continues to outperform the market in Mainland China, where RevPAR declined 2 percent.

Looking ahead, the company expects to accelerate net system size in the coming quarter and it is on track to exceed 5 percent for full year 2019.

The company remains confident in financial outcome for the rest of the year, despite the weaker RevPAR environment, and the challenges some of its markets are currently experiencing.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Global PC shipments returned to growth in the second quarter of 2020 after seeing a significant decline in the preceding first quarter due to COVID-19 related supply-chain disruptions, according to reports by two research firms. The PC market returned to growth in the quarter as production ramped up and vendors restocked their supplies to near-normal levels. The bankruptcy filing of America's oldest apparel retailer Brooks Brothers has ignited significant interest from potential buyers for the brand. WHP Global and a venture backed by Authentic Brands Group LLC and Simon Property Group, Inc., are reportedly considering bids for the retailer. WHP Global owns the ANNE KLEIN and JOSEPH ABBOUD brands. Sundial Herbal Products has recalled around 65 products, which were misbranded and currently unapproved drugs, the U.S. Food and Drug Administration said in a statement. The recall follows an order by a federal judge in June to stop distributing the company's unapproved new drugs. The affected items include herbal products and dietary supplements.
Follow RTT